Business Daily Media

Australia's approach to trade rules restraining vaccine production

  • Written by Deborah Gleeson, Associate professor, La Trobe University

Papua New Guinea’s COVID-19 outbreak is a portent of the “catastrophic moral failure[1]” the head of the World Health Organization warned of in January due to poor countries being pushed to the back of the vaccine queue.

Australia has gifted 8,000 doses to PNG, and vowed to help the nation of almost 9 million secure 1 million more[2]. Earlier this month Australia agreed to work with the US, India and Japan to provide 1 billion vaccines[3] to poorer countries in the Asia-Pacific. It is also supporting COVAX[4], the global program aiming to buy and distribute 2 billion COVID-19 vaccine doses to developing nations by the end of 2021.

But all this could be negated through Australia’s potential spoiling role (with a handful of other countries) against a proposal supported by 118 countries to ramp up vaccine production by relaxing the trade rules governing intellectual property.

Inequities in access to COVID-19 vaccines

The inequities in access to vaccines are stark. By November, wealthy nations accounting for just 14% of the global population[5] had locked in premarket agreements to buy 51% of the first 7.48 billion doses of candidate COVID-19 vaccines.

That number should be enough to vaccinate almost half the global population – 3.76 billion of 7.8 billion people. But Canada, Australia, Britain, Japan, the European Union and the US have all bought up more than their fair share. Canada has reserved about 4.5 courses per person; Australia and the UK close to 2.5.

Australia's approach to trade rules restraining vaccine production Anthony D. So/British Medical Journal[6] This means most middle-income countries won’t achieve widespread vaccination coverage until late 2022, according to The Economist’s Intelligence Unit[7]. For poorer economies, including some of Australia’s closest neighbours, it won’t be “before 2023, if at all”. Australia's approach to trade rules restraining vaccine production The Economist Intelligence Unit[8] Suspending intellectual property rules Addressing vaccine inequities, the director-general of the World Health Organization, Tedros Adhanom Ghebreyesus has said, requires pulling “out all the stops[9]”. One of those stops is the international agreement protecting intellectual property rights – the Agreement on Trade-Related Aspects of Intellectual Property Rights, commonly called the TRIPS agreement[10]. All members of the World Trade Organization are bound by the agreement. In October 2020, South Africa and India proposed waiving[11] certain provisions of TRIPS that give the owners of the intellectual property exclusive rights over the manufacture and sale of COVID vaccines. The waiver would only apply to COVID-19 medical products and only for the duration of the pandemic. This would allow others to make COVID-19 vaccines without the vaccine developers’ permission. Australia's approach to trade rules restraining vaccine production Medecins Sans Frontieres members deploy a banner in front of the headquarters of the World Trade Organization in Geneva on March 4 2021. Martial Trezzini/EPA The TRIPS waiver is supported by 118[12] of the WTO’s 164 members – more than two-thirds of its membership. The counter-proposal supported by Australia Australia, however, has joined with Canada, Chile, Colombia, New Zealand, Norway and Turkey in supporting a counter-proposal[13] that argues provisions already in the TRIPS agreement are good enough. TRIPS does allow for compulsory licensing, enabling the use of a patent without the consent of the owner, in a public health emergency. But the compulsory licensing process is time-consuming and only applies to patents, not the other types of intellectual property important for making vaccines. A vaccination centre in Mumbai, India, on March 10 2021. A vaccination centre in Mumbai, India, on March 10 2021. Rajanish Kakade/AP The counter-proposal put its faith in encouraging more talk between vaccine developers and manufacturers, enabling them to make voluntary licensing agreements and identify ways to increase production. But there’s little reason to think this would achieve more than what is already happening. For example, AstraZeneca has licensed the Serum Institute of India[14] to make its vaccine both for India and other countries. Read more: Yes, export bans on vaccines are a problem, but why is the supply of vaccines so limited in the first place?[15] Voluntary licences are problematic because they are ad hoc and confidential. The lack of transparency has seen pricing discrepancies[16] such as Bangladesh and South Africa reportedly paying more for their AstraZeneca doses than European nations. Voluntary licences can also place tight restrictions on where the resulting products can be sold. For example, when US pharmaceutical company Gilead Sciences negotiated licences with makers in India, Pakistan and Egypt to produce a cheaper version of Remdesivir (a candidate for COVID-19 treatment in the early stages of the pandemic) the licence conditions excluded many middle-income countries[17] from buying the cheaper version. Australia’s support for this counter-proposal is therefore a distraction at best. It can’t bring about the fundamental change the TRIPS waiver could generate. Nor is it likely to lead to the world being vaccinated sooner.

References

  1. ^ catastrophic moral failure (www.bbc.com)
  2. ^ 1 million more (www.abc.net.au)
  3. ^ to provide 1 billion vaccines (www.theguardian.com)
  4. ^ COVAX (www.who.int)
  5. ^ 14% of the global population (www.bmj.com)
  6. ^ Anthony D. So/British Medical Journal (www.ignitetheidea.org)
  7. ^ The Economist’s Intelligence Unit (www.eiu.com)
  8. ^ The Economist Intelligence Unit (www.eiu.com)
  9. ^ out all the stops (www.theguardian.com)
  10. ^ TRIPS agreement (www.wto.org)
  11. ^ proposed waiving (docs.wto.org)
  12. ^ 118 (www.twn.my)
  13. ^ counter-proposal (docs.wto.org)
  14. ^ Serum Institute of India (economictimes.indiatimes.com)
  15. ^ Yes, export bans on vaccines are a problem, but why is the supply of vaccines so limited in the first place? (theconversation.com)
  16. ^ pricing discrepancies (www.politico.eu)
  17. ^ excluded many middle-income countries (www.citizen.org)

Authors: Deborah Gleeson, Associate professor, La Trobe University

Read more https://theconversation.com/more-talk-no-action-australias-approach-to-trade-rules-restraining-vaccine-production-156971

Business Today

3 in 4 fundraisers have experienced sexual harassment on the job – often because of inappropriate behavior from donors

Sexual harassment is a common workplace hazard for nonprofit fundraisers.fizkes/iStock/Getty Images PlusWhile the #MeToo movement that raised public awareness of sexual harassment is making fewer headlines than it did in 2017 and ...

Cathay Pacific 2021 Sustainability Report

New commitments in carbon neutrality and diversity, and supporting the Hong Kong community during the pandemicThe Cathay Pacific Group has released its annual Sustainable Development Report that addresses its commitment and prog...

Cozycozy, is tackling consumer manipulation in the travel industry

With its user-centric algorithm, Cozycozy fights against the Online Travel Agencies' rampant manipulation of consumers’ choices. In 2019, 112.3 million domestic trips and 11.3 Million international trips were taken by Austral...

Foreign companies exiting Russia echo the pressure campaign against South Africa's racist apartheid system

McDonald's is leaving Russia after three decades of operating there.Sefa Karacan/Anadolu Agency via Getty ImagesMcDonald’s provided many Russians with their first taste of capitalism three decades ago. Now, the global fast-f...

Jennifer Westacott's interview with Ross Greenwood

Ross Greenwood, host, Business Now: Joining us is the chief executive of the Business Council of Australia, Jennifer Westacott. Jennifer, many thanks for your time as always. Quite clearly the government is setting out its age...

Business success as Aussie kids skateboard brand, Ookkie, launches in UK and Europe

Australia’s leading kids skateboard company, Ookkie, has set the wheels in motion for global business success, expanding into two new overseas markets thanks to growing demand for its products from ‘skateboard loving paren...

Business Daily Media Business Development

Rishi Sunak's £15 billion cost-of-living package and windfall tax: four experts respond

Rishi Sunak, the UK chancellor of the exchequer, has unveiled a £15 billion package of measures to help households with the cost of living, after energy watchdog Ofgem announced it wou...

Jonquil Lowe, Senior Lecturer in Economics and Personal Finance, The Open University - avatar Jonquil Lowe, Senior Lecturer in Economics and Personal Finance, The Open University

the economic tactics that drive Liverpool and Real Madrid

Liverpool against Real Madrid in the Champions League final is a fixture for football fans to savour – two giants battling it out for one of the most prized trophies in the game. And r...

Simon Chadwick, Global Professor of Sport | Director of Eurasian Sport, EM Lyon - avatar Simon Chadwick, Global Professor of Sport | Director of Eurasian Sport, EM Lyon

Cathay Pacific 2021 Sustainability Report

New commitments in carbon neutrality and diversity, and supporting the Hong Kong community during the pandemicThe Cathay Pacific Group has released its annual Sustainable Development Repor...

Business Daily Media - avatar Business Daily Media

Cozycozy, is tackling consumer manipulation in the travel industry

With its user-centric algorithm, Cozycozy fights against the Online Travel Agencies' rampant manipulation of consumers’ choices. In 2019, 112.3 million domestic trips and 11.3 Million i...

Business Daily Media - avatar Business Daily Media

How to talk to your employer about trauma

Chanintorn.v / ShutterstockThe impact of trauma and post-traumatic stress disorder (PTSD) is a hidden chronic mental health issue in the workplace. A 2016 survey of UK adults found that one ...

Stefanos Nachmias, Principal Lecturer and Deputy Head of HRM Department, Nottingham Trent University - avatar Stefanos Nachmias, Principal Lecturer and Deputy Head of HRM Department, Nottingham Trent University

Jennifer Westacott's interview with Ross Greenwood

Ross Greenwood, host, Business Now: Joining us is the chief executive of the Business Council of Australia, Jennifer Westacott. Jennifer, many thanks for your time as always. Quite clear...

Ross Greenwood - avatar Ross Greenwood



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion